Automated External Defibrillators Market

Automated External Defibrillators Market Outlook (2022-2032)

The global automated external defibrillator market is expected to be worth US$ 17 Billion in 2022, with a CAGR of 11% during the forecast period. Sales of automated external defibrillators is expected to reach a valuation of US$ 48.26 Billion by 2032. 

Automated external defibrillators are life-saving devices that aid in cardiac rhythm correction. The growing prevalence of cardiac diseases, the rising geriatric population, and technological advancements in the field, supported by increasing investments from market players, are the major factors driving the growth of the automated electronic defibrillator market.

Report Attributes	Details
Anticipated Base Year Value (2021)	US$ 15 Billion
Expected Market Value (2022)	US$ 17 Billion
Projected Forecast Value (2032)	US$ 48.26 Billion
Global Growth Rate (2022-2032)	11% CAGR
Growth Rate of the U.S (2022-2032)	8% CAGR
Expected Market Value of China (2032)	US$ 10 Billion
Key Service Providers	Koninklijke Philips Physio-Control Inc. (Stryker) Nihon Koden Corporation Asahi Kasei Medical Co. Ltd GE Healthcare Ltd.

Automated defibrillators are devices that analyze the heart rhythm automatically and, if a problem is detected, respond by delivering an electric shock to restore normal heart rhythm. Because of its small size and ease of use, AEDs are installed in a variety of settings (including hospitals and airports) and play an important role in increasing the number of opportunities for life-saving defibrillation.

The major factors driving market growth are technological advancements in automated defibrillators, an increase in the prevalence of cardiovascular diseases, and rapid growth in the ageing population. Furthermore, the increased emphasis on providing public access defibrillators fuels market growth. In contrast, increased pricing pressure on market participants restrains market growth.

Automated External Defibrillators Market Revenue Analysis 2015-2021 vs. Future Outlook 2022-2032

As per market research and competitive intelligence provider Fact.MR, the market for automated external defibrillators witnessed a 12.2% CAGR from 2015 to 2021. The market for automated external defibrillators is expanding due to a variety of factors, one of which is an increase in the prevalence of cardiovascular diseases.

According to World Health Organization data, cardiovascular diseases (CVD) are the leading cause of death in the world, killing an estimated 17.9 million people each year (2021). Myocardial infarction, congestive heart failure, acute coronary syndrome, and other conditions are examples of CVDs.

In addition to the statistics mentioned above, the previously mentioned source stated that stroke and heart attack account for more than four-fifths of all cardiovascular disease deaths, and one-third of these deaths occur in people under the age of 70.  In cases of cardiac arrest, automated external defibrillators are widely used to resuscitate the heart.

As a result, the rising prevalence of cardiovascular diseases is expected to increase demand for automated external defibrillator. During the forecast period from 2022 to 2032, the global automated external defibrillators market is expected to grow at a CAGR of 11%.

Prominent Automated External Defibrillators Industry Growth Drivers

Increased Prevalence of Cardiac Arrest Drives Demand for Defibrillators

The automated external defibrillator is gaining popularity due to its ability to help restore irregularities in heart rhythm using an electric shock to the heart. These devices are designed to detect and treat two types of abnormal heart rhythms: ventricular fibrillation (VF) and pulseless ventricular tachycardia (PVT) (pulseless VT).

The increased use of this device in the treatment of patients suffering from sudden cardiac arrest is expected to create revenue-generating opportunities in the global automated external defibrillators market in the coming years. Furthermore, an increase in the number of people addicted to alcohol and smoking may create lucrative opportunities in the market.

Offering Device Use Training Programs in the Workplace to Support Market Sales

AEDs are used in a variety of settings, including emergency medical services, hospitals, public access, work spaces, homes, and private cardiac clinics. The demand for this device is expected to rise in workplaces around the world as stress levels rise. Training for the proper use of an automated external defibrillator device may aid in the prevention of unfortunate events such as cardiac arrest deaths. As a result, various training programmes are being implemented to ensure that these devices are used correctly in offices.

Key Challenges Prevalent in the Global Automated External Defibrillators Market

Resistance to Adopt Digital Transformation may Impede Growth Prospects

Stringent regulations, as well as a lack of awareness and early corrective measures regarding Sudden Cardiac Arrest (SAC), may impede the growth of the studied market over the forecast period.

Country-wise Analysis

What is the Growth Outlook for Automated External Defibrillators in the U.S?

The United States will dominate the global market for automated external defibrillators. The rising prevalence of sudden cardiac arrests is cited as a major reason for the high market share. In the forecast period, the availability of automated external defibrillators is expected to boost market share. Furthermore, increased government intervention in advocating for increased use of automated external defibrillators is expected to fuel market growth. Between 2022 and 2032, the CAGR is expected to be 8%.

According to the American Heart Association's Heart & Stroke Statistics - 2020 Update, over 356,000 out-of-hospital cardiac arrests occur in the United States each year, with nearly 90% of them being fatal. In the United States, the estimated number of out-of-hospital cardiac arrests (OHCA) among adults was 347,322. Because emergency medical services take an average of four to ten minutes to reach someone in cardiac arrest, less than half (45.7 percent) of cardiac arrest victims receive immediate help before emergency responders arrive.

However, if automated external defibrillators (AEDs) are available nearby, the high mortality rate from out-of-hospital cardiac arrests can be reduced, which may increase demand for AEDs in the country, projecting the market's growth.

Furthermore, according to the Centers for Disease Control and Prevention's September 2021 report, approximately 659,000 people in the United States die from heart diseases each year, and approximately 805,000 people suffer a heart attack each year. Because of the high prevalence of heart attacks, the market studied in the United States is expected to grow.

The rising prevalence of cardiovascular diseases in Canada, increased R&D investment, and increased awareness of defibrillators in the country are expected to drive the growth of the automated external defibrillators market over the forecast period.

According to a June 2020 article published by the Canadian Centre for Occupational Health and Safety (CCOHS), more than 40,000 people die in Canada each year from sudden cardiac arrest, which equates to one person every 12 minutes and more than 100 people per day. Because of the high number of sudden cardiac arrests in the country, there is a high demand for automated external defibrillators (AEDs), which can save lives.

As a result, the market is expected to expand during the forecast period. According to the source, many other medical conditions and lifestyle choices, such as diabetes, overweight and obesity, an unhealthy diet, excessive alcohol consumption, and physical inactivity, can increase the risk of heart disease.

How do Growth Prospects appear in the Chinese Market?

The Chinese Market Exhibits Potential

In the future, China has enormous growth potential. A growing population, which will result in an increase in cardiovascular diseases, is expected to drive market growth. During the forecast period, projections show an impressive 7.7% growth.

Other factors that are likely to drive the growth of the automated external defibrillator market include an increase in severe physical stress as a result of a heavy mental work load, smoking, and physical inactivity.  Moreover, players in the automated external defibrillator market are expected to profit in China due to increased investment and a rise in the prevalence of cardiac disorders in the region.

Country-wise Forecast CAGRs in the Automated External Defibrillators Market

Country	CAGR
U.S	8%
U.K	7%
China	7.7%
Japan	6.3%
South Korea	6%

Category-wise Insights

Why is Demand for Fully Automated Defibrillators rising Rapidly?

Fully automated defibrillators are expected to grow rapidly, with semi-automatic defibrillators catching up

During the forecast period, fully-automated external defibrillators are expected to be widely used by a variety of healthcare institutions. The main reason for growth is the delivery of high amplitude current impulses to restore normal heart function. In the forecast period, the CAGR for fully automated defibrillators is expected to be 7.3%.

Semi-automatic defibrillators, on the other hand, will account for a sizable portion of the market. The ease of use provided by clear voice prompts is a major factor in the popularity of semi-automatic defibrillators. Furthermore, practitioners with little or no training can use this device.

Which End User will Leverage Automated External Defibrillators the Most?

Traction to be Maximum across Hospitals

The market has been segmented by end user into hospitals, public access, emergency medical services, homes, work spaces and private cardiac clinics. The hospitals segment had the largest market share in 2020 and is expected to continue to follow the same trend during the forecast period (2022-2032).

Due to an increase in the number of sudden cardiac arrest cases worldwide, the public access segment is expected to grow at a significant rate in the next ten years.

Competitive Landscape

The market for automated external defibrillators is highly consolidated. Among the key players are:

• Koninklijke Philips
• Physio-Control Inc. (Stryker)
• Nihon Koden Corporation
• Asahi Kasei Medical Co. Ltd
• GE Healthcare Ltd.

Through mergers, acquisitions, and alliances, these companies have gained a competitive advantage. Strengthening the product portfolio by introducing new products is another important strategy for the companies' market dominance.

Automated External Defibrillators (AEDs) are available through Koninklijke Philips' Healthcare division. These include HeartStart AEDs such as the FR3, OnSite, and FRx. Because of its light weight and manoeuvrability in tight spaces, the HearStart FR3, for example, is simple to use. It can withstand harsh environments and is easily configurable. Overall, Philips Healthcare provides its clients with a wide range of cardiovascular solutions. The company is a pioneer in the development of treatments for sudden cardiac arrest. It provides solutions that advance minimally invasive procedures for patients with coronary and peripheral artery disease.

Stryker's Physio-Control Inc. develops, manufactures, and sells defibrillators and cardiopulmonary resuscitation assist devices. The HeartSine Samaritan PAD 350P, HeartSine Samaritan PAD 360P, LIFEPAK 100 Defibrillator, and LIFEPAK CR Plus are among its products. The PAD 350P and 360P AEDs analyze heart rhythm and, if necessary, deliver a shock. The rescuer is no longer required to press the shock button. Furthermore, these devices include an automated external defibrillator programme manager that alerts the user to any issues that may affect device readiness. This reduces the time and money required to manage the automated external defibrillator programme.

Key Segments Covered the Automated External Defibrillators Industry Report

• By Key Technologies

  • Semi-Automatic 
  • Fully-Automatic 

• By Key sizes

  • Standard 
  • Pediatric

• By End Users

  • Hospitals
  • Public Access
  • Emergency Medical Services
  • Homes
  • Work Spaces
  • Private Cardiac Clinics

• By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa